Cardiovascular-Related Mortality Risk in Primary Myelofibrosis in Pre-Ruxolitinib and Ruxolitinib Eras

被引：0

作者：

Ilerhunmwuwa, Nosakhare Paul ^{[1
]}

Rayapureddy, Aditya Keerthi ^{[2
]}

Uche, Ifeanyi Nnamdi ^{[1
]}

Wasifuddin, Mustafa ^{[3
]}

Wang, Jen-Chin ^{[4
]}

机构：

[1] Brookdale Univ Hosp & Med Ctr, Dept Med, Brooklyn, NY USA

[2] Interfaith Med Ctr, Dept Med, Brooklyn, NY USA

[3] Brookdale Univ Hosp & Med Ctr, Brooklyn, NY USA

[4] Brookdale Univ Hosp & Med Ctr, Div Hematol Oncol, Brooklyn, NY USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-174418

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[21] RISK FACTORS FOR INFECTIONS IN RUXOLITINIB-TREATED MYELOFIBROSIS PATIENTS [J].

Polverelli, N. ;

Benevolo, G. ;

Nicolosi, M. ;

Catani, L. ;

Romano, M. ;

Campana, A. ;

Sollazzo, D. ;

Perricone, M. ;

Testoni, N. ;

Vitolo, U. ;

Martinelli, G. ;

Cavo, M. ;

Vianelli, N. ;

Palandri, F. .

HAEMATOLOGICA, 2015, 100 :112-113

[22] SURVIVAL AND RISK OF DEATH ANALYSIS OF PATIENTS WITH MYELOFIBROSIS TREATED WITH RUXOLITINIB [J].

Stoeva, V ;

Mihaylov, G. ;

Tachkov, K. ;

Petrova, G. .

VALUE IN HEALTH, 2023, 26 (12) :S248-S248

[23] Ruxolitinib Reduces Oxidative Stress in Patients With Primary Myelofibrosis: A Multicenter Study [J].

Koyuncu, Mahmut B. ;

Ilgan, Mustafa ;

Basir, Hakan ;

Tombak, Anil ;

Ucar, Mehmet Ali ;

Koseci, Tolga ;

Akdeniz, Aydan ;

Tiftik, Eyup N. ;

Erel, Ozcan .

CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (01)

[24] The Journey of Primary Myelofibrosis to Splenic Marginal Zone Lymphoma on the Wheels of Ruxolitinib [J].

Dass, Jasmita ;

Langer, Sabina ;

Kotwal, Jyoti ;

Gupta, Nitin .

INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2021, 37 (01) :186-188

[25] Cryptococcal infection with ruxolitinib in primary myelofibrosis: A case report and literature review [J].

Ciochetto, Zachary ;

Wainaina, Njeri ;

Graham, Mary Beth ;

Corey, Anna ;

Abid, Muhammad Bilal .

CLINICAL CASE REPORTS, 2022, 10 (02)

[26] Pulmonary tuberculosis reactivation following ruxolitinib treatment in a patient with primary myelofibrosis [J].

Chen, Yen-Hao ;

Lee, Chen-Hsiang ;

Pei, Sung-Nan .

LEUKEMIA & LYMPHOMA, 2015, 56 (05) :1528-1529

[27] Ruxolitinib therapy is associated with improved renal function in patients with primary myelofibrosis [J].

Paolo Strati ;

Maen Abdelrahim ;

Umut Selamet ;

Valda D. Page ;

Sherry A. Pierce ;

Srdan Verstovsek ;

Ala Abudayyeh .

Annals of Hematology, 2019, 98 :1611-1616

[28] Ruxolitinib therapy is associated with improved renal function in patients with primary myelofibrosis [J].

Strati, Paolo ;

Abdelrahim, Maen ;

Selamet, Umut ;

Page, Valda D. ;

Pierce, Sherry A. ;

Verstovsek, Srdan ;

Abudayyeh, Ala .

ANNALS OF HEMATOLOGY, 2019, 98 (07) :1611-1616

[29] TREATMENT WITH RUXOLITINIB IN PATIENTS WITH PRIMARY OR SECONDARY MYELOFIBROSIS: SINGLE CENTER EXPERIENCE [J].

Sotiropoulos, D. ;

Papaioannou, G. ;

Iskas, M. ;

Karavalakis, G. ;

Bousiou, Z. ;

Athanasiadou, A. ;

Gaitatzi, M. ;

Stavroyianni, N. ;

Lalayanni, C. ;

Touloumenidou, T. ;

Kalaitzidou, V. ;

Anagnostopoulos, A. .

HAEMATOLOGICA, 2015, 100 :759-760

[30] Use of rifampin for treatment of disseminated tuberculosis in a patient with primary myelofibrosis on ruxolitinib [J].

Benoit Branco ;

David Metsu ;

Marine Dutertre ;

Bruno Marchou ;

Pierre Delobel ;

Christian Recher ;

Guillaume Martin-Blondel .

Annals of Hematology, 2016, 95 :1207-1209

← 1 2 3 4 5 →